China Cracks Down on Fake Data in Drug Trials
Researchers and manufacturers face possible jail time — or execution — for fraudulent submissions to nation's drug agency.
Send us a link
Researchers and manufacturers face possible jail time — or execution — for fraudulent submissions to nation's drug agency.
Rise in copyright breaches prompts industry to discuss ways to allow ‘fair sharing’ of articles.
Funders should force universities to support laboratories’ research health
Alfredo Fusco denies claims that his research lab hired a photo studio to manipulate images.
Science panels still rely on poor proxies to judge quality and impact.
Nature journals have signed up to the principles of the Declaration on Research Assessment agreement.
Journal editors tend to accept manuscripts written by prior collaborators more quickly.
They say they don't have the time or incentives to do research — and that’s dangerous for translational medicine.
Analysis reveals that female researchers are over-represented on the social-media site and that mathematicians and life scientists are less likely to use it.
Beth Simone Noveck urges researchers to work out how technology can improve public institutions.
The Nature Index tracks the affiliations of high-quality scientific articles. The infographic indicates patterns of international collaboration captured by the Nature Index.
Without data on how artificial intelligence is affecting jobs, policymakers will fly blind into the next industrial revolution, say Tom Mitchell and Erik Brynjolfsson.
Male scientists in the United Kingdom report teaching less than their female counterparts, while women and minorities tend to feel disadvantaged in their careers.
Linguists, anthropologists and political scientists take to Capitol Hill to defend their research.
If you are terrified to meet with your supervisor, start with small doses.
US Food and Drug Administration says firm can provide consumers with information on genetic risks.
The political left and right share an interest in science in general, but not science in particular. the political left and right share an interest in science in general, but not science in particular.
Cheap, stripped-down microcontrollers are allowing users to pack huge amounts of computing power into tiny spaces.
New tool joins a growing collection of software for accessing fee-for-view scientific literature.
Funnel plots are a popular tool in spotting when scientists in a field leave out negative study results, but one researcher says the method is flawed.
Papers from 2015 are a tougher read than some from the nineteenth century — and the problem isn't just about words, says Philip Ball.
More than 30% of biomedical studies funded by the US government are later cited in commercial patents.
An analysis of more than 50 collaborations shows the secrets of success, write Joel Cutcher-Gershenfeld and colleagues from the Stakeholder Alignment Collaborative.
Beleaguered institution cancels presidential election two days before vote, and appoints acting chief.
Global health charity is latest funder to start its own publishing ‘channel’ — and the European Commission is considering its own service.